CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.

about

Assessing the relationship between toxicity and economic cost of oncological target agents: A systematic review of clinical trials.

P2860

Q38614152-90C54BF1-6465-4851-ABBD-81741A21D1B1

P2860

CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.

Item

http://www.wikidata.org/entity/Q47323391

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.

@en

CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.

@nl

type

Item

label

CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.

@en

CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.

@nl

prefLabel

CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.

@en

CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.

@nl

P1476

CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL

@en

P2093

Alberto Russi

http://www.w3.org/2001/XMLSchema#string

Angelo Claudio Palozzo

http://www.w3.org/2001/XMLSchema#string

Jacopo Pigozzo

http://www.w3.org/2001/XMLSchema#string

P2860

Development and external validation of a prognostic nomogram for metastatic uveal melanoma

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Do the current performance-based schemes in Italy really work? "Success fee": a novel measure for cost-containment of drug expenditure.

Drug waste minimization as an effective strategy of cost-containment in oncology.

Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients.

A centralized Pharmacy Unit for cytotoxic drugs in accordance with Italian legislation.

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.

A preliminary analysis of the reduction of chemotherapy waste in the treatment of cancer with centralization of drug preparation.

P304

199-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S0266462317000332

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

V Damuzzo

V Chiarion-Sileni

Francesca Di Sarra

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28703084

http://www.w3.org/2001/XMLSchema#string

P921

Ipilimumaab

CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.

about

P2860

P2860

CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921